KORTUC is featured in the lead story of the October 14 edition of “Science Japan”, the Japan Science and Technology Agency’s (JST’s) online magazine that offers a comprehensive overview of breaking science & technology news from Japan. The article highlighted KORTUC’s amazing business progress, as well as the history of the company since its founding and its now proven technology.
KORTUC is strongly supported by JST, one of Japan’s largest national research funding agencies. The company’s visionary strategy to target the global market for new oncology therapies completely aligns with the Japanese Government’s strategy to foster globally-oriented Japanese bio-startups.
KORTUC aims to directly grow in the US and EU markets with its ongoing pivotal Phase 2 study in the UK and other planned clinical studies in the US and Europe.
Further information can be found below: